Daniel Steinberg

Concepts (325)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Transcatheter Aortic Valve Replacement
14
2022
90
5.280
Why?
Aortic Valve Stenosis
16
2022
177
4.360
Why?
Angioplasty, Balloon, Coronary
35
2012
178
3.940
Why?
Coronary Artery Disease
28
2020
696
3.030
Why?
Heart Valve Prosthesis Implantation
9
2022
164
2.670
Why?
Coronary Angiography
47
2021
866
2.600
Why?
Drug-Eluting Stents
20
2012
51
2.600
Why?
Cardiac Catheterization
17
2022
419
2.340
Why?
Stents
22
2022
657
1.910
Why?
Aortic Valve
14
2022
249
1.900
Why?
Coronary Restenosis
18
2016
42
1.730
Why?
Heart Valve Prosthesis
6
2020
222
1.570
Why?
Computed Tomography Angiography
11
2021
424
1.500
Why?
Fractional Flow Reserve, Myocardial
11
2021
137
1.440
Why?
Coronary Stenosis
13
2018
246
1.330
Why?
Ultrasonography, Interventional
12
2019
119
1.280
Why?
Myocardial Infarction
21
2013
807
1.240
Why?
Tomography, X-Ray Computed
15
2022
2324
1.120
Why?
Sirolimus
13
2012
118
1.110
Why?
Calcinosis
5
2019
241
1.100
Why?
Coronary Thrombosis
10
2009
45
1.060
Why?
Cardiovascular Agents
6
2012
82
1.030
Why?
Foramen Ovale, Patent
4
2015
21
1.010
Why?
Coronary Vessels
11
2022
313
1.000
Why?
Paclitaxel
11
2012
140
0.940
Why?
Percutaneous Coronary Intervention
5
2019
137
0.850
Why?
Mitral Valve Insufficiency
4
2018
99
0.840
Why?
Humans
116
2022
68549
0.840
Why?
Coronary Occlusion
2
2020
12
0.810
Why?
Plaque, Atherosclerotic
5
2016
125
0.810
Why?
Bioprosthesis
3
2018
101
0.800
Why?
Treatment Outcome
47
2022
7028
0.770
Why?
Prosthesis Design
17
2018
301
0.710
Why?
Heart Valve Diseases
3
2022
123
0.710
Why?
Mitral Valve
4
2018
166
0.710
Why?
Retrospective Studies
48
2021
7268
0.690
Why?
Heparin
8
2017
205
0.680
Why?
Hemodynamic Monitoring
1
2019
6
0.670
Why?
Coronary Disease
7
2008
358
0.640
Why?
Coronary Artery Bypass
7
2022
218
0.640
Why?
Male
86
2022
37283
0.640
Why?
Aged
63
2022
14842
0.640
Why?
Contrast Media
7
2016
595
0.630
Why?
Middle Aged
67
2022
21119
0.610
Why?
Anticoagulants
6
2017
356
0.610
Why?
Iliac Artery
2
2015
44
0.600
Why?
Female
82
2022
38021
0.600
Why?
Septal Occluder Device
2
2015
21
0.590
Why?
Thoracotomy
1
2017
25
0.580
Why?
Autonomic Nerve Block
1
2017
15
0.580
Why?
Secondary Prevention
3
2015
291
0.570
Why?
Peptide Fragments
6
2012
483
0.570
Why?
Hemodynamics
9
2022
705
0.570
Why?
Radial Artery
2
2019
43
0.560
Why?
Hirudins
6
2012
32
0.560
Why?
Ischemic Attack, Transient
2
2015
167
0.560
Why?
Saphenous Vein
4
2009
61
0.540
Why?
Graft Occlusion, Vascular
4
2009
73
0.540
Why?
Acute Coronary Syndrome
4
2017
195
0.510
Why?
Angina Pectoris
4
2013
61
0.510
Why?
Aortography
1
2015
72
0.510
Why?
Hemorrhage
5
2017
328
0.500
Why?
Pain, Postoperative
1
2017
214
0.490
Why?
Time Factors
24
2018
4655
0.470
Why?
Arteries
2
2020
108
0.470
Why?
Cardiovascular Diseases
7
2010
938
0.460
Why?
Machine Learning
4
2019
170
0.460
Why?
Platelet Aggregation Inhibitors
8
2012
373
0.450
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2012
80
0.430
Why?
Feasibility Studies
9
2022
652
0.430
Why?
Predictive Value of Tests
16
2020
1465
0.420
Why?
Fluoroscopy
3
2020
152
0.420
Why?
Thrombosis
6
2010
218
0.410
Why?
Diagnostic Imaging
2
2015
201
0.410
Why?
Risk Assessment
15
2021
2004
0.410
Why?
Vascular Calcification
3
2019
131
0.400
Why?
Prosthesis Failure
2
2015
130
0.400
Why?
Severity of Illness Index
17
2019
1851
0.400
Why?
Shock, Cardiogenic
3
2018
23
0.400
Why?
Heart
2
2016
850
0.390
Why?
Pulmonary Wedge Pressure
3
2022
102
0.380
Why?
Angina, Unstable
2
2008
50
0.370
Why?
Patient Safety
1
2012
202
0.350
Why?
Aged, 80 and over
16
2022
4843
0.350
Why?
Metals
6
2010
100
0.350
Why?
Ticlopidine
5
2009
118
0.330
Why?
Risk Factors
18
2019
5720
0.320
Why?
Prospective Studies
12
2022
3703
0.310
Why?
Spectroscopy, Near-Infrared
4
2013
31
0.310
Why?
Follow-Up Studies
21
2021
3256
0.300
Why?
Balloon Occlusion
1
2007
22
0.300
Why?
Prognosis
9
2019
2093
0.290
Why?
Hypertension, Pulmonary
2
2020
232
0.290
Why?
Device Removal
1
2007
100
0.280
Why?
Blood Pressure
3
2022
1449
0.270
Why?
Stroke
4
2015
2162
0.270
Why?
Registries
8
2019
730
0.270
Why?
Preoperative Care
3
2021
275
0.270
Why?
Thermography
1
2005
20
0.270
Why?
Drug Delivery Systems
1
2007
236
0.250
Why?
Reproducibility of Results
10
2020
2077
0.230
Why?
Kaplan-Meier Estimate
9
2012
536
0.230
Why?
Recombinant Proteins
6
2012
742
0.230
Why?
Heart Failure
4
2022
1179
0.220
Why?
Radiographic Image Interpretation, Computer-Assisted
4
2019
373
0.220
Why?
ROC Curve
7
2017
392
0.220
Why?
Germany
4
2016
67
0.210
Why?
Vena Cava, Superior
1
2022
41
0.200
Why?
Decision Making
2
2017
410
0.200
Why?
Aneurysm, False
1
2022
60
0.200
Why?
Recurrence
6
2015
948
0.200
Why?
Patient Selection
4
2013
592
0.190
Why?
Catheterization, Peripheral
2
2019
38
0.190
Why?
Heart Atria
1
2022
206
0.190
Why?
Lipids
2
2013
298
0.190
Why?
Tricuspid Valve Insufficiency
1
2020
25
0.180
Why?
Multimodal Imaging
2
2022
62
0.180
Why?
Tubulin Modulators
2
2012
10
0.180
Why?
Immunosuppressive Agents
5
2012
514
0.180
Why?
Transposition of Great Vessels
1
2020
51
0.180
Why?
Cardiomyopathy, Hypertrophic
2
2013
116
0.180
Why?
Echocardiography, Transesophageal
3
2015
100
0.170
Why?
Japan
1
2019
68
0.170
Why?
Catheters
1
2019
39
0.170
Why?
Vascular Endothelial Growth Factor D
1
2019
10
0.170
Why?
Obesity
2
2017
1074
0.170
Why?
Myocardial Ischemia
3
2013
172
0.170
Why?
Diagnosis, Computer-Assisted
1
2019
75
0.160
Why?
Radiation Dosage
3
2016
419
0.160
Why?
Triiodobenzoic Acids
2
2015
28
0.160
Why?
Cardiac-Gated Imaging Techniques
2
2015
60
0.160
Why?
Patient Care Planning
2
2015
108
0.160
Why?
Pulmonary Artery
1
2020
323
0.160
Why?
Sensitivity and Specificity
6
2019
1753
0.160
Why?
Blood Vessel Prosthesis Implantation
3
2008
186
0.150
Why?
Equipment Design
3
2012
500
0.150
Why?
Myocardial Revascularization
2
2008
56
0.150
Why?
Coated Materials, Biocompatible
2
2008
54
0.150
Why?
Echocardiography
2
2022
515
0.150
Why?
Heart Diseases
3
2009
276
0.150
Why?
Ventricular Function, Right
1
2018
103
0.150
Why?
Prosthesis Implantation
1
2018
83
0.150
Why?
Coronary Circulation
3
2013
136
0.140
Why?
Adult
12
2022
21379
0.140
Why?
Incidence
6
2013
1582
0.140
Why?
Survival Rate
5
2017
1055
0.140
Why?
South Carolina
2
2013
2752
0.130
Why?
Magnetic Resonance Imaging
3
2016
2222
0.130
Why?
Thrombectomy
2
2009
238
0.130
Why?
Everolimus
2
2012
26
0.130
Why?
Signal-To-Noise Ratio
1
2015
93
0.130
Why?
Heart-Assist Devices
1
2018
221
0.130
Why?
Cohort Studies
5
2017
2356
0.120
Why?
Ventricular Function, Left
1
2018
481
0.120
Why?
Ethanol
2
2013
892
0.120
Why?
Multidetector Computed Tomography
1
2014
60
0.120
Why?
Forecasting
1
2015
277
0.110
Why?
Patient Outcome Assessment
1
2013
42
0.110
Why?
Embolism, Paradoxical
1
2013
6
0.110
Why?
Disease Progression
3
2019
1037
0.110
Why?
Logistic Models
6
2016
1419
0.110
Why?
Troponin I
2
2011
34
0.110
Why?
Blood Flow Velocity
1
2013
172
0.110
Why?
Ablation Techniques
1
2013
33
0.110
Why?
Deep Sedation
1
2012
11
0.110
Why?
Anesthesia, Local
1
2012
14
0.110
Why?
Sympathectomy
1
2012
24
0.110
Why?
Angiography
1
2013
194
0.110
Why?
Mitral Valve Annuloplasty
1
2012
6
0.100
Why?
Postoperative Complications
2
2011
1615
0.100
Why?
Embolism, Cholesterol
1
2011
3
0.100
Why?
Multivariate Analysis
5
2016
1046
0.100
Why?
Electrocardiography
3
2009
601
0.100
Why?
Hospitals, Teaching
1
2012
65
0.100
Why?
Image Processing, Computer-Assisted
1
2015
689
0.100
Why?
Acute Disease
3
2009
658
0.100
Why?
Drug Utilization
1
2012
119
0.100
Why?
Creatine Kinase, MB Form
2
2008
20
0.100
Why?
Area Under Curve
3
2016
238
0.100
Why?
Fellowships and Scholarships
1
2012
127
0.090
Why?
Vascular Patency
3
2019
122
0.090
Why?
Angioplasty
1
2011
118
0.090
Why?
Cardiology
1
2012
140
0.090
Why?
Reoperation
2
2009
467
0.090
Why?
Catheter Ablation
1
2012
229
0.090
Why?
Diabetes Complications
2
2008
249
0.090
Why?
Tomography, Spiral Computed
1
2009
57
0.090
Why?
Peripheral Vascular Diseases
1
2009
50
0.090
Why?
Proportional Hazards Models
5
2009
791
0.090
Why?
Takotsubo Cardiomyopathy
1
2009
14
0.090
Why?
Biomarkers
5
2019
1593
0.090
Why?
Suction
1
2009
33
0.080
Why?
Thrombocytopenia
1
2010
122
0.080
Why?
Elasticity Imaging Techniques
1
2009
14
0.080
Why?
Femoral Artery
1
2009
139
0.080
Why?
Safety
2
2007
145
0.080
Why?
Embolism
1
2008
45
0.080
Why?
Emergencies
1
2009
107
0.080
Why?
Filtration
1
2008
61
0.080
Why?
Platelet Membrane Glycoprotein IIb
1
2008
4
0.080
Why?
Tomography, Optical Coherence
1
2009
88
0.080
Why?
Iopamidol
1
2008
37
0.080
Why?
Tomography, Emission-Computed, Single-Photon
1
2009
137
0.080
Why?
Length of Stay
1
2012
780
0.080
Why?
Minimally Invasive Surgical Procedures
1
2009
85
0.080
Why?
Heart Septum
1
2008
84
0.080
Why?
Integrin beta3
1
2008
35
0.080
Why?
Hospital Mortality
4
2013
384
0.080
Why?
Stroke Volume
2
2022
586
0.080
Why?
Device Approval
1
2007
6
0.080
Why?
Body Mass Index
3
2016
866
0.080
Why?
Solvents
1
2008
109
0.080
Why?
Myocardial Contraction
1
2009
383
0.080
Why?
Kidney
1
2012
945
0.070
Why?
Creatinine
1
2008
243
0.070
Why?
Equipment Safety
1
2007
50
0.070
Why?
Heart Septal Defects, Atrial
1
2007
37
0.070
Why?
Renal Dialysis
1
2008
174
0.070
Why?
Odds Ratio
3
2016
880
0.070
Why?
Radiography, Interventional
1
2007
49
0.070
Why?
Hypolipidemic Agents
1
2007
82
0.070
Why?
United States
5
2017
7338
0.070
Why?
Contraindications
1
2007
52
0.070
Why?
Atherectomy, Coronary
1
2006
5
0.070
Why?
Congresses as Topic
1
2007
85
0.070
Why?
Atrial Fibrillation
1
2009
248
0.070
Why?
Comorbidity
4
2013
1425
0.070
Why?
Clinical Competence
1
2012
657
0.070
Why?
Hospitalization
2
2010
977
0.070
Why?
Algorithms
3
2018
1195
0.070
Why?
Thrombolytic Therapy
1
2008
233
0.070
Why?
Prostheses and Implants
1
2007
159
0.070
Why?
Double-Blind Method
1
2010
1738
0.070
Why?
Fibrinolytic Agents
1
2009
377
0.070
Why?
Patient Compliance
1
2008
402
0.070
Why?
Kidney Diseases
1
2008
307
0.060
Why?
Kidney Failure, Chronic
1
2008
365
0.060
Why?
Healthcare Disparities
1
2009
378
0.060
Why?
District of Columbia
3
2009
23
0.060
Why?
Catheterization
1
2005
209
0.060
Why?
Insulin
1
2008
617
0.060
Why?
Anti-Inflammatory Agents
1
2006
234
0.060
Why?
Heart Ventricles
1
2009
738
0.060
Why?
Chronic Disease
3
2019
1329
0.060
Why?
Aortic Valve Insufficiency
2
2014
47
0.050
Why?
Hypertension
1
2012
1533
0.050
Why?
Prevalence
1
2007
1609
0.050
Why?
Sternotomy
1
2022
18
0.050
Why?
Recovery of Function
2
2018
506
0.050
Why?
Diabetes Mellitus
1
2008
694
0.050
Why?
Ultrasonography
2
2015
453
0.050
Why?
Young Adult
3
2022
5710
0.050
Why?
Ulnar Artery
1
2019
2
0.040
Why?
Vasoconstriction
1
2019
81
0.040
Why?
Lymphangiogenesis
1
2019
10
0.040
Why?
Asia
1
2019
59
0.040
Why?
North America
1
2019
111
0.040
Why?
Benchmarking
1
2019
91
0.040
Why?
Europe
1
2019
196
0.040
Why?
Drug Therapy, Combination
2
2012
648
0.040
Why?
Arterial Occlusive Diseases
1
2019
134
0.040
Why?
Adolescent
3
2022
8904
0.040
Why?
Hospitals, University
1
2019
169
0.040
Why?
Consensus
1
2019
211
0.040
Why?
Hydrodynamics
1
2018
15
0.040
Why?
Retreatment
2
2007
59
0.040
Why?
Partial Thromboplastin Time
1
2017
57
0.040
Why?
Adaptation, Physiological
1
2018
189
0.040
Why?
Age Factors
2
2013
1860
0.030
Why?
Infusions, Intravenous
1
2017
334
0.030
Why?
Regression Analysis
2
2008
737
0.030
Why?
Magnetic Resonance Imaging, Interventional
1
2015
5
0.030
Why?
Radiation Exposure
1
2016
84
0.030
Why?
Overweight
1
2017
186
0.030
Why?
Healthy Volunteers
1
2015
78
0.030
Why?
Vasodilator Agents
1
2016
138
0.030
Why?
Academic Medical Centers
1
2017
281
0.030
Why?
Obesity, Morbid
1
2017
172
0.030
Why?
Sesquiterpenes
1
2014
41
0.030
Why?
Magnetic Resonance Angiography
1
2015
181
0.030
Why?
Case-Control Studies
2
2008
1549
0.030
Why?
Ultrasonography, Doppler
1
2013
57
0.030
Why?
Imaging, Three-Dimensional
1
2015
333
0.030
Why?
Randomized Controlled Trials as Topic
2
2007
929
0.030
Why?
Dose-Response Relationship, Drug
1
2017
1745
0.030
Why?
Adenosine
1
2013
165
0.030
Why?
Statistics as Topic
1
2013
219
0.030
Why?
Radiography
1
2013
572
0.030
Why?
Office Visits
1
2012
83
0.030
Why?
Blood Pressure Monitoring, Ambulatory
1
2012
89
0.030
Why?
Creatine Kinase
1
2011
46
0.030
Why?
Drug Resistance
1
2012
223
0.020
Why?
Cardiac Pacing, Artificial
1
2012
174
0.020
Why?
Arrhythmias, Cardiac
1
2012
239
0.020
Why?
Cineangiography
1
2009
15
0.020
Why?
Injections, Intra-Arterial
1
2009
30
0.020
Why?
Platelet Count
1
2010
100
0.020
Why?
Angiography, Digital Subtraction
1
2009
63
0.020
Why?
Intra-Aortic Balloon Pumping
1
2009
20
0.020
Why?
Aorta, Abdominal
1
2009
97
0.020
Why?
Immunoenzyme Techniques
1
2009
196
0.020
Why?
Contusions
1
2008
11
0.020
Why?
Observation
1
2008
30
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2009
88
0.020
Why?
Creatine
1
2008
30
0.020
Why?
Disease-Free Survival
1
2009
349
0.020
Why?
Social Class
1
2009
127
0.020
Why?
Antihypertensive Agents
1
2012
497
0.020
Why?
Pilot Projects
1
2012
1341
0.020
Why?
Injections
1
2008
119
0.020
Why?
Injections, Intravenous
1
2008
215
0.020
Why?
Treatment Failure
1
2008
216
0.020
Why?
Confidence Intervals
1
2008
242
0.020
Why?
Drug Administration Schedule
1
2009
567
0.020
Why?
Drug Labeling
1
2007
32
0.020
Why?
Cause of Death
1
2008
241
0.020
Why?
Aspirin
1
2009
295
0.020
Why?
Survival Analysis
1
2009
714
0.020
Why?
Chi-Square Distribution
1
2008
546
0.020
Why?
Diagnosis, Differential
1
2008
1140
0.020
Why?
Heart Defects, Congenital
1
2009
596
0.010
Why?
Brain Ischemia
1
2009
665
0.010
Why?
Research Design
1
2007
729
0.010
Why?
Practice Guidelines as Topic
1
2007
772
0.010
Why?
Animals
1
2009
20880
0.010
Why?
Steinberg's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (325)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_